Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis
Mark H. Ebell, Henry C Barry, Kanishka Baduni, Gabrielle Grasso
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1370/afm.3050
- Published
- Jan 1, 2024
- Venue
- The Annals of Family Medicine
- DOI
- 10.1370/afm.3050
- PubMed
- 38253509
- Categories
- Alzheimer's disease research and treatments
- Provenance
- openalex